New splicing mutation of MEN1 gene affecting the translocation of menin to the nucleous

Journal of Endocrinological Investigation

Volumn 29, Issue 10, 2006, Pages 888-893

  Tala, H P ^a   Carvajal, C A ^a   Gonzalez A A ^a   Garrido, J L ^a   Tobar, J ^a   Solar, A ^a   Campino, C ^a   Arteaga, E ^a   Fardella, C E ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

MEN1 gene; MEN1 syndrome; Menin; Primary hyperparathyroidism

Indexed keywords

GLYCINE; MESSENGER RNA; METHIONINE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1 PROTEIN; NUCLEAR PROTEIN; RESTRICTION ENDONUCLEASE; THREONINE; UNCLASSIFIED DRUG;

ADRENAL HYPERPLASIA; ADULT; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL NUCLEUS; CHO CELL; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FAMILY; FEMALE; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC TRANSFECTION; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPARATHYROIDISM; IMMUNOBLOTTING; IN VITRO STUDY; INTRON; LEUKOCYTE; MALE; MOLECULAR SIZE; MULTIPLE ENDOCRINE NEOPLASIA; MUTANT; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PANCREAS TUMOR; PROTEIN TRANSPORT; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; RNA SPLICING; SCHOOL CHILD; WESTERN BLOTTING; WILD TYPE;

EID: 33846476303     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03349192     Document Type: Article

References (23)

1. Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001, 86: 5658-71.
2. Guo S, Sawicki M. Molecular and genetic mechanisms of tumorigenesis in multiple endocrine neoplasia type-1. Mol Endocrinol 2000, 15: 1653-64.
3. Yaguchi H, Ohkura N, Takahashi M, Nagamura Y, Kitabayashi I, Tsukada T. Men in missense mutants associated with multiple endocrine neoplasia type 1 are rapidly degraded via the ubiquitin-proteasome pathway. Mol Cell Biol 2004, 15: 6569-80.
4. Chandrasekharappa SC, Guru SC, Manickam P, et al. Positional cloning of the gene for multiple endocrine neoplasia type 1. Science 1997, 276: 404-7.
5. Agarwal SK, Guru SC, Heppner C, et al. Menin interacts with the AP1 transcription factor Jun D and represses JunD-activated transcription. Cell 1999, 96: 143-52.
6. Weitzman JB, Fiette L, Matsuo K, Yaniv M. JunD protects cells from p53-dependent senescence and apoptosis. Mol Cell 2000, 6: 1109-19.
7. Chandrasekharappa SC, Teh BT. Functional studies of the MEN1 gene. J Intern Med 2003, 253: 606-15.
8. Vieira JG, Tachibana TT, Obara LH, Maciel RB. Extensive experience and validation of polyethylene glycol (PEG) precipitation as screening method for macroprolactinemia. Clin Chem 1998, 44: 1758-9.
9. Carrasco C, Gonzalez A, Carvajal C, et al. Novel intronic mutation of MEN1 gene causing familial isolated primary hyperparathyroidism. J Clin Endocrinol Metab 2004, 89: 4124-9.
10. Marx SJ. Molecular genetics of multiple endocrine neoplasia types 1 and 2. Nat Rev Cancer 2005, 5: 367-75.
11. Hou SH, Grossman S, Molitch ME. Hyperprolactinemia in patients with renal insufficiency and chronic renal failure requiring hemodialysis or chronic ambulatory peritoneal dialysis. Am J Kidney Dis 1985, 6: 245-49.
12. Iglesias P, Diez JJ, Fernandez-Reyes MJ, et al. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis. Clin Endocrinol (Oxf) 2004, 60: 741-9.
13. Bonetti B, Fu L, Moon J, Bedwell DM. The efficiency of translation termination is determined by a synergistic interplay between upstream and downstream sequences in Saccharomyces cerevisiae. J Mol Biol 1995, 251: 334-45.
14. Bale AE, Norton JA, Wong EL. Allelic loss on chromosome 11 in hereditay and sporadic tumors related to familial multiple endocrine neoplasia type 1. Cancer Res 1991, 51: 1154-7.
15. Bystrom C, Larsson C, Blomberg C. Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci USA 1990, 87: 1968-72.
16. Radford DM, Ashley SW, Wells Jr SA, Gerhard DS. Loss of heterozygosity of markers on chromosome 11 in tumors from patients with multiple endocrine neoplasia syndrome type 1. Cancer Res 1990, 50: 6529-33.
17. Sawicki MP, Wan YJ, Johnson CL, Berenson J, Gatti R, Passaro Jr E. Loss of heterozygosity on chromosome 11 in sporadic gastrinomas. Hum Genet 1992, 89: 445-9.
18. Friedman E, De Marco L, Gejman PV. Allelic loss from chromosome 11 in parathyroid tumors. Cancer Res 1992 52: 6804-9.
19. Debelenko LV, Zhuang Z, Emmert-Buck MR. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors. Cancer Res 1997, 57: 2238-43.
20. Lubensky IA, Debelenko LV, Zhuang Z, et al. Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients. Cancer Res 1996, 56: 5272-8.
21. Eubanks PJ, Sawicki MP, Samara GJ. Pancreatic endocrine tumors with loss of heterozygosity at the multiple endocrine neoplasia type I locus. Am J Surg 1997, 173: 518-20.
22. Ikeo Y, Sakurai A, Hashizume K. Characterization of the MEN1 gene produce, menin, by site-specific polyclonal antibodies. Jpn J Cancer Res 1999, 90: 1088-95.
23. Wautot V, Vercherat C, Lespinasse J, et al. Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein. Human Mutation 2002, 20: 35-47.